23011000087103: SHINGRIX 50 micrograms per 0.5 milliliter powder and suspension for suspension for injection GlaxoSmithKline Inc. (real clinical drug)

SNOMED CT Concept\produit pharmaceutique ou biologique\Medicinal product (product)\...

\Vaccine product\Virus antigen-containing vaccine product\Vaccine product containing Human alphaherpesvirus 3 antigen (medicinal product)\Human alphaherpesvirus 3 antigen only vaccine product\...

\Vaccine product containing only Human alphaherpesvirus 3 antigen for herpes zoster prevention (medicinal product)\Zos zoster non-live adjuvanted unspecified\Zos SHINGRIX GSK

\Vaccine product containing only Human alphaherpesvirus 3 recombinant surface glycoprotein E antigen (medicinal product)\Zos SHINGRIX GSK

\Product manufactured as parenteral dose form (product)\Zos SHINGRIX GSK

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Apr 2018. Module: Canada Health Infoway English module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module

105791000087113 SHINGRIX 50 micrograms per 0.5 milliliter powder and suspension for suspension for injection GlaxoSmithKline Inc. en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) Canada Health Infoway English module (core metadata concept)

105801000087112 Zos SHINGRIX GSK en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) Canada Health Infoway English module (core metadata concept)

105881000087117 Zona SHINGRIX GSK fr Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) Canada Health Infoway French module (core metadata concept)

137601000087114 SHINGRIX 50 micrograms per 0.5 milliliter powder and suspension for suspension for injection GlaxoSmithKline Inc. (real clinical drug) en Fully specified name Active Entire term case sensitive (core metadata concept) Canada Health Infoway English module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Zos SHINGRIX GSK	a pour principe actif (attribut)	Varicella-zoster virus surface glycoprotein E antigen	true	Inferred relationship	Some	1
Zos SHINGRIX GSK	Plays role	Active immunity stimulant role (role)	true	Inferred relationship	Some
Zos SHINGRIX GSK	a une forme pharmaceutique (attribut)	forme pharmaceutique pour usage parentéral (forme pharmaceutique)	true	Inferred relationship	Some
Zos SHINGRIX GSK	Has product characteristic	Adjuvanted vaccine product (qualifier value)	true	Inferred relationship	Some
Zos SHINGRIX GSK	Has supplier	GlaxoSmithKline Inc. (supplier)	true	Inferred relationship	Some
Zos SHINGRIX GSK	est un(e) (attribut)	Product manufactured as parenteral dose form (product)	true	Inferred relationship	Some
Zos SHINGRIX GSK	Count of base of active ingredient	un	false	Inferred relationship	Some
Zos SHINGRIX GSK	est un(e) (attribut)	Vaccine product containing only Human alphaherpesvirus 3 recombinant surface glycoprotein E antigen (medicinal product)	true	Inferred relationship	Some
Zos SHINGRIX GSK	a pour principe actif (attribut)	Varicella virus vaccine (substance)	false	Inferred relationship	Some	1
Zos SHINGRIX GSK	est un(e) (attribut)	Zos zoster non-live adjuvanted unspecified	true	Inferred relationship	Some

Inbound Relationships

Type

Active

Source

Characteristic

Refinability

Group

Reference Sets

Canada English language reference set (foundation metadata concept)

Administered tradename codes for vaccines reference set (foundation metadata concept)